Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT
Journal article
Iro MA. et al, (2024), Efficacy and Mechanism Evaluation, 1 - 53
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Journal article
Hayward G. et al, (2024), Journal of Infection, 88
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
Journal article
Standing JF. et al, (2024), Nature communications, 15
supporting people with type 2 diabetes diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial
Journal article
FARMER A., (2024), Pilot and Feasibility Studies
Nurse-delivered sleep restriction therapy in primary care for adults with insomnia disorder: a mixed-methods process evaluation.
Journal article
Armstrong S. et al, (2024), Br J Gen Pract, 74, e34 - e40
Informed consent in randomised controlled trials: further development and evaluation of the participatory and informed consent (PIC) measure
Journal article
Wade J. et al, (2023), Trials, 24
Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children
Journal article
Kazmin D. et al, (2023), npj Vaccines, 8
Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial
Journal article
Hill M. et al, (2023), BMJ open, 13
Penicillin allergy status and its effect on antibiotic prescribing, patient outcomes and antimicrobial resistance (ALABAMA): protocol for a multicentre, parallel-arm, open-label, randomised pragmatic trial
Journal article
Armitage KF. et al, (2023), BMJ Open, 13
A targeted psychological treatment for sleep problems in young people at ultra-high risk of psychosis in England (SleepWell): a parallel group, single-blind, randomised controlled feasibility trial
Journal article
Waite F. et al, (2023), The Lancet Psychiatry, 10, 706 - 718
Platform adaptive trial of novel antivirals for early treatment of COVID-19 in the community (PANORAMIC): Protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
Journal article
Gbinigie O. et al, (2023), BMJ Open, 13
AN EARLY CLINICAL PHASE COMPARISON OF AN AUTOMATED VR COGNITIVE THERAPY WITH VR MENTAL RELAXATION THERAPY FOR THE TREATMENT OF PERSISTENT PERSECUTORY DELUSIONS IN PATIENTS DIAGNOSED WITH PSYCHOSIS (THRIVE): A PARALLEL GROUP, SINGLE-BLIND, RANDOMISED CONTROLLED TRIAL IN ENGLAND WITH MEDIATION ANALYSES.
Journal article
FREEMAN D., (2023), Lancet Psychiatry
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study
Journal article
Nicholson BD. et al, (2023), The Lancet Oncology, 24, 733 - 743
Culturally Adapting a Digital Intervention to Reduce Suicidal Ideation for Syrian Asylum Seekers and Refugees in the United Kingdom: Protocol for a Qualitative Study.
Journal article
Beuthin O. et al, (2023), JMIR Res Protoc, 12
Dietary Approaches to the Management Of type 2 Diabetes (DIAMOND) in primary care: A protocol for a cluster randomised trial
Journal article
Scragg J. et al, (2023), Contemporary Clinical Trials, 129
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Journal article
Butler CC. et al, (2023), The Lancet, 401, 281 - 293